Trusted Clinical Genomics Infrastructure
Smart Genome combines clinical whole genome reporting, genomic interpretation, and large-scale genome exploration in a unified platform for healthcare, research, and precision medicine.
Built on years of clinical reporting experience and validated genomic methodologies, Simplify Genomics helps organizations transform genomic data into clinically meaningful insights and actionable knowledge.
New clinical and health and wellness insights—powering more informed care and better outcomes.
Alzheimer’s Disease Risk
Expanded Pharmacogenomics
New Health and Wellness Insights
Clinical Genomics Infrastructure
Simplify Genomics combines clinical reporting expertise, curated genomic knowledge, and scalable genomic infrastructure to support healthcare, research, and precision medicine programs.
- CLIA-certified and CAP-accredited genomic reporting
- Clinical Whole Genome reporting since 2018
- Hereditary Disease, Polygenic Risk, Pharmacogenomics, and Health and Wellness Trait reporting
- Clinical Decision Support with Genetic Counselor services
Built on genomic infrastructure originally developed at Human Longevity, Inc. and more than eight years of clinical whole-genome reporting experience.
Featured Resources
- Simplify Genomics Expands Its Smart Genome™ Platform with GCR v10Clinical Genomics Company, spun out of Human Longevity, adds integrated Alzheimer’s risk assessment and expands pharmacogenomics and wellness insights. SAN DIEGO, Calif. — September 15, 2026 — Simplify Genomics, the clinical genomics company built from genomic intelligence originally developed at Human Longevity, Inc. (HLI), today announced Version 10 of its Genomic Clinical Report (GCR). This version was developed… Read More »Simplify Genomics Expands Its Smart Genome™ Platform with GCR v10
- Actionability in Genomic Medicine: More Than Choosing the Right DrugThe concept of actionability in genetics is frequently associated with identifying genetic variants that directly inform therapeutic intervention. In pharmacogenomics, actionability often means using genetic information that may inform treatment selection and dosing for an individual. Cholesterol management is an excellent example. Although low-density lipoprotein (LDL), a lipoprotein particle that carries cholesterol, is often referred to as “bad cholesterol,” cholesterol… Read More »Actionability in Genomic Medicine: More Than Choosing the Right Drug
Genomic Findings
Learn how the Smart GenomeTM platform unifies genomic information in one platform and how our approach can be applied to transform patient care in your organization.
1.6M+ variants interpreted
2000+ genes and 2100+ hereditary disease associations curated
CLIA-certified and CAP-accredited Whole Genome Sequence reporting since 2018
~1.5 Billion queryable variant records
Let’s discuss your needs
We can provision your genomic data in a fast, queryable, secure platform